Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302

Citation:

Teply BA, Qiu F, Antonarakis ES, Carducci MA, Denmeade SR. Prostate. 2019 Jun;79(8):929-933. doi: 10.1002/pros.23798.